Edition:
United States

Anges MG Inc (4563.T)

4563.T on Tokyo Stock Exchange

239JPY
2 Dec 2016
Change (% chg)

¥-5 (-2.05%)
Prev Close
¥244
Open
¥245
Day's High
¥246
Day's Low
¥239
Volume
533,700
Avg. Vol
1,579,975
52-wk High
¥943
52-wk Low
¥209

4563.T

Chart for 4563.T

About

AnGes MG, Inc. is mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidate... (more)
No analyst recommendations are available for 4563.T.

Overall

Beta: 1.16
Market Cap(Mil.): ¥17,233.98
Shares Outstanding(Mil.): 70.63
Dividend: --
Yield (%): --

Financials

  4563.T Industry Sector
P/E (TTM): -- 42.21 29.87
EPS (TTM): -83.02 -- --
ROI: -94.60 -1.09 14.95
ROE: -95.82 -2.39 16.29

BRIEF-AnGes MG announces exercise of 10,300 options

* Says 10,300 of 28th warrants were exercised into 1.03 million shares of its common stock from Sept. 26 to Sept. 28, including 150,000 shares at exercise price 258 yen, 200,000 shares at 242 yen and 680,000 shares at 234 yen per share

Sep 28 2016

BRIEF-AnGes MG announces exercise of 13,681 options

* Says 13,681 of 28th warrants were exercised into 1.37 million shares of its common stock from Sept. 16 to Sept. 23, including 150,000 shares at exercise price 209 yen and 200,000 shares at 206 yen etc.

Sep 23 2016

BRIEF-AnGes MG announces exercise of 22,500 options

* Says 22,500 of 28th warrants were exercised into 2.25 million shares of its common stock from Sep. 14 to Sep. 15, including 250,000 shares at exercise price 222 yen and 2 million shares at 214 yen

Sep 15 2016

BRIEF-Anges MG announces exercise of options

* Says 8,700 of 28th warrants were exercised into 870,000 shares of its common shares from Sep. 7 to Sep. 13, comprised of 170,000 shares at exercise price 233 yen, 270,000 shares at 230 yen, 100,000 shares at 234 yen, 180,000 shares at 229 yen and 150,000 at 219 yen

Sep 13 2016

BRIEF-Anges MG announces exercise of options

* Says 8,800 units of its 28th series options were exercised to 880,000 shares of its common stock from Aug. 23 to Aug. 30

Aug 30 2016

BRIEF-Anges MG to work together with Vical Incorporated on DNA vaccine business

* Says the company and Vical Incorporated has agreed to work together on DNA vaccine business, which includes research, development and manufacturing

Aug 12 2016

BRIEF-AnGes MG to invest Vical and to hold 18.6 pct stake in it

* Says it to buy 1,841,420 shares of Vical Inc for $4.2448 per share on Aug. 3

Aug 01 2016

BRIEF-AnGes MG to grant development manufacturing and marketing rights to Morishita Jintan

* Says it reached basic agreement with Morishita Jintan Co Ltd on June 16

Jun 15 2016

Earnings vs. Estimates